Skip to main content
Premium Trial:

Request an Annual Quote

NIGMS-funded Michigan Center to Serve as Drug Development Data Resource

NEW YORK (GenomeWeb News) – The University of Michigan will create a new molecular data center that will serve as a free resource for drug designers and pharmacology software developers, according to the National Institutes of Health.
The five-year program, called the Community Structure-Activity Resource, will receive up to $5 million over five years through the National Institute of General Medical Sciences.
The CSAR will collect molecular data from existing resources, will work with other researchers to generate new data, and will be involved in collecting unpublished data from researchers at pharmaceutical companies.
"If we know the structure of a compound bound to a drug target, we should be able to tell how tightly the compound binds — information critical to drug development,” NIGMS Director Jeremy Berg said in a statement.
“But, in practice, we are not able to do this well enough to contribute significantly to research progress,” he said. "This resource has been established to make important structural and binding data available so researchers can tackle this problem."
The program will be led by UM College of Pharmacy chemist Heather Carlson, who will oversee the development and operation of CSAR.
The researchers also will use Carlson’s Binding MOAD (“Mother of All Databases”), which holds over 11,000 protein-ligand complexes, and the PDBbind database, which provides experimentally measured binding data.
CSAR scientists also will try to use experiments to close gaps in the data, and will sponsor community-wide events to spur more scientific collaboration.

Filed under

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.